High Tide Welcomes White House Executive Order Advancing Cannabis Rescheduling
High Tide welcomed the Executive Order issued by the White House advancing the rescheduling of cannabis as well as an announcement that the Centers for Medicare & Medicaid Services is expected to launch a pilot program allowing certain Medicare beneficiaries to receive CBD treatments at no cost. "Given the imminent move toward cannabis rescheduling, the Company has begun evaluating the feasibility of expanding its flagship bricks-and-mortar retail brand, Canna Cabana, into the United States through a licensing model. In parallel, the Company's hemp-derived CBD brands, NuLeaf Naturals and FAB CBD, are well-positioned to benefit from rescheduling and the potential inclusion of CBD products within Medicare Advantage supplemental benefits. This positioning is supported by THC-free and broad-spectrum product formats that align with compliant Medicare benefit catalogs, CGMP-certified operations, and USDA organic product certifications. NuLeaf's breadth, scale, and premium positioning enable long-term category leadership through a dedicated, Medicare-ready offering, while FAB's purpose-driven, simplified dosing assortment is designed to support faster adoption across Medicare Advantage plans. Both NuLeaf and FAB will begin evaluating Medicare-aligned product categories as a result of today's news. In addition, the Company is pleased to announce that it has reengaged IR Agency effective December 19, 2025, to provide investor relations services, supporting the Company's communications with existing and prospective shareholders, the investment community and stakeholders," the company stated.
Trade with 70% Backtested Accuracy
Analyst Views on HITI
About HITI
About the author

- Earnings Highlights: High Tide Inc. reported a Q4 Non-GAAP EPS of C$0.02, indicating limited profitability but demonstrating the company's stability in the market.
- Revenue Growth: The company achieved Q4 revenue of C$164.03 million, representing an 18.6% year-over-year increase, which highlights significant sales growth in the competitive discount cannabis retail market.
- Market Position: As a discount cannabis retailer, High Tide Inc. maintains a relatively hidden competitive advantage despite industry challenges, attracting investor interest.
- Quant Rating: Seeking Alpha's Quant Rating on High Tide Inc. reflects cautious optimism regarding its future performance, indicating investor concern over its financial health.
- Earnings Announcement Date: High Tide (HITI) is set to release its Q4 earnings on January 29 after market close, with a consensus EPS estimate of $0.01, reflecting a significant year-over-year increase of 116.7%, indicating improved profitability.
- Revenue Expectations Decline: Despite the optimistic EPS forecast, the revenue estimate stands at $116.1 million, representing a 16.1% year-over-year decline, suggesting increased market competition and sales pressure may impact overall performance.
- Historical Performance Review: Over the past two years, HITI has only beaten EPS estimates 13% of the time, yet has exceeded revenue estimates 100% of the time, indicating strong revenue management despite fluctuations in profitability.
- Market Attention: As a discount cannabis retailer, High Tide's hidden position in the market, despite facing challenges, may present unique opportunities for investors, warranting close attention to its future financial performance and market strategies.
- Options Market Volatility: The options market is experiencing heightened volatility due to the upcoming Federal Reserve policy decision, with some stocks showing implied volatility nearing 50% ahead of earnings reports.
- Capitol Federal Financial: CFFN is set to report earnings on January 28, with analysts expecting earnings per share of 15 cents and revenue of $57.51 million, reflecting a significant implied move of 48.48%.
- Other Bank Stocks: Stocks like First Financial Bancorp and Provident Financial Services are also seeing implied moves exceeding 39%, indicating cautious market sentiment regarding their earnings performance.
- Market Reaction: Overall, the market is reacting strongly to the impending earnings reports, particularly among regional banks, highlighting investor concerns over future earnings uncertainty and potential risks.
- Earnings Release Schedule: High Tide is set to announce its financial and operational results for the year ending October 31, 2025, after market close on January 29, 2026, which is expected to provide critical performance metrics for investors to assess the company's financial health.
- Webcast Interaction: Following the earnings release, High Tide will host a webcast on January 30, 2026, at 11:30 AM ET, featuring CEO Raj Grover and CFO Mayank Mahajan, aimed at providing in-depth insights into the financial results and outlining strategic plans for 2026.
- Market Reaction Expectations: The timing of the earnings release and webcast may influence investor confidence in High Tide's stock, especially given the company's recognition as one of Canada's fastest-growing companies, which could heighten market expectations for its future performance.
- Global Business Footprint: High Tide's subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally with 218 locations and a 12% market share, and this earnings report will showcase its competitive positioning and business expansion strategies in the rapidly growing cannabis market.
- Store Expansion: High Tide successfully opened over 200 Canna Cabana locations in 2025, marking its evolution from a single store in 2018 to a globally recognized brand, thereby enhancing its competitive edge in the Canadian market.
- Membership Growth: The Canna Cabana membership surpassed 2 million, indicating a significant increase in customer loyalty and market penetration, further solidifying its market leadership.
- International Market Entry: High Tide officially entered the German medical cannabis market, becoming the first North American cannabis operator to establish a physical presence in Germany, signaling substantial growth potential in international markets.
- Financial Performance: Since the legalization of cannabis in Canada, High Tide has achieved over $2 billion in cumulative sales, demonstrating its robust operating model and positive cash flow, which is expected to support future expansion efforts.
- Market Expansion: In 2025, High Tide successfully entered the German medical cannabis market by acquiring a majority stake in Remexian Pharma GmbH, becoming one of the largest medical cannabis importers in Germany, marking a significant step in its globalization strategy.
- Sales Growth: As of 2025, High Tide has surpassed $2 billion in cumulative sales, with a 7.4% year-over-year increase in same-store sales during the third fiscal quarter, demonstrating strong market demand and brand influence.
- Membership Growth: The Cabana Club membership has exceeded 2.4 million, establishing itself as the largest bricks-and-mortar cannabis loyalty program globally, further solidifying High Tide's leadership position in the retail market.
- Store Expansion: In 2025, High Tide added 27 new Canna Cabana locations, bringing the total to 218, exceeding its target and enhancing its competitive advantage in the Canadian market.










